Bibliografía.
1. WHO. Mental health: depression. [Definición en línea] 2000.[Citado el 6 de enero de 2008]. Disponible en: http://www.who.int/mental_health/management/depression/definition/en/2. The world health report 2001. Mental health: new understanding, new hope. New York: WHO, 2001.
2. Lara-González E. Prevalencia de depresión mayor en pacientes hospitalizados (tesis). México: Facultad de Medicina, Universidad Autónoma de Yucatán, 2001.
3. SSA. Programa específico de depresión. [Serie en línea]2002. [Citado el 6 de enero de 2008] Disponible en: http://sersame.salud.gob.mx/depresion.htm
4. Ayuso-Mateos JS, Vázquez-Barquero JS, Dowrick C, Lehtinen V, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry 2001;179:308-16.
5. Galli E. La depresión: hacia una nueva conceptualización dimensional. Alcmeón Revista Argentina de Clínica Neuropsiquiátrica. [Serial online] 1997;2(1). [Disponible en: http://www.alcmeon.com.ar/6/22/a22_05.htm]
6. Medina-Mora ME, Borges G, Lara-Muñoz C, Benjet C, et al. Prevalencia de trastornos mentales y uso de servicios: resultados de la Encuesta Nacional de Epidemiología Psiquiátrica en México. Salud Mental 2003;26:1-16.
7. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psichiatry 2000;57(10):1552-62.
8. Dubovsky SL, Buzan R. Trastornos del estado de ánimo. En: Hales RE, Yudofsky SC, editores. Sinopsis de psiquiatría clínica. Basado en DSM IV, Tratado de psiquiatría. 3ª ed. Barcelona: Masson, 2000;pp:287-341.
9. Rusisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003; 54:227-240.
10. Kauffmann MW, Fitzgibbons JP, Sussman EJ, et al.Relation between myocardial infarction, depresión, hostility, and death. Am Heart H 1999; 138: 549-54.
11. Frasure-Smith N, Lesperance F, Talajic M. Depresion following myocardial infarction: impact on 6 month survival. JAMA 1993; 273: 1819-25.
12. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, Fauerbach JA Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2002; 1: 89:112-3.
13. Lane D, Carroll D, Lip GY. Anxiety, depression, and prognosis after myocardial infarction: is there a causal association? J Am Coll Cardiol 2003; 19: 42: 1808-10.
14. Ziegelstein RC. Depression in patients recovering from a myocardial infarction. JAMA 2001; 286: 1621-7.
15. Lesperance F, Frasure-Smith N, Juneau M, Theroux P. Major depression before and after myocardial infarction: Its nature and consequences. Psychosom Med 1996; 58: 99-110. 13.
16. Valdés M, de Pablo J, Campos R, Farré JM, Girón M, Institut Clinic de Psiquiatria, et al. El proyecto multinacional europeo y multicéntrico español de mejora de calidad asistencial en psiquiatría de enlace en el hospital general: el perfil clínico en España. Med Clin 2000; 115: 690-4.
17. Guck TP, Kavan MG, Elsasser GN, Barone EJ. Assessment and treatment of depression following myocardial infarction. Am Fam Physician 2001; 15: 64: 641-8. Review.
18. Mallik S, Krumholz HM, Lin ZQ, Kasl SV, Mattera JA, Roumains SA, Vaccarino V. Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery.Circulation 2005; 25:111: 271-7. Epub 2005 Jan 17. 28. Salaycik KJ, Kelly-Hayes M, Beiser A, Nguyen AH, Brady S, Kase CS, et al.
19. Depressive symptoms and risk of stroke: the Framingham Study. Stroke 2007; 38: 16-21.
20. Lehto S, Koukkunen H, Hintikka J, Viinamaki H, Laakso M, Pyorala K. Depression after coronary heart disease events. Scand Cardiovasc J 2000; 34: 580-3.
21. Camacho TC, Roberts RE, Lazarus NB, Kaplan GA, Cohen RD. Physical activity and depression: evidence from the Alameda County Study. Am J Epidemiol 1991; 134: 220-31.
22. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069-78.
23. Thakore JH, Richards PJ, Reznek RH, Martin A, Dinan TG. Increased intraabdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry 1997; 41: 1140-2.
24. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-7.
25. Shemesh E, Yehuda R, Milo O, Dinur I, Rudnick A, Vered Z, et al. Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction. Psychosom Med 2004; 66: 521-6.
26. Siever LJ, Davis KL. Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry 1985; 142: 1017-31. 35.
27. Siever LJ, Davis KL. Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry 1985; 142: 1017-31.
28. Carney RM, Freedland KE, Veith RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 2005; 67: s29-s33.
29. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995; 76: 562-4.
30. Brunckhorst CB, Holzmeister J, Scharf C, Binggeli C, Duru F. Stress, depression and cardiac arrhythmias. Ther Umsch 2003; 60: 673-81.
31. Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitaryadrenal axis. Biol Psychol 2001; 57: 141-52.
32. Gold PW, Licinio J, Wong ML, Chrousos GP. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann N Y Acad Sci 1995; 771: 716-29.
33. Kasckow JW, Baker D, Geracioti TD, Jr. Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides 2001; 22: 845-51.
34. Sachar EJ, Hellman L, Fukushima DK, Gallagher TF. Cortisol production in depressive illness: a clinical and biochemical clarification. Arch Gen Psychiatry 1970; 23: 289–98.
35. Kathol RG, Jaeckle RS, Lopez JF, Meller WH. Consistent reduction of ACTH responses to stimulation with CRH, vasopressin, and hypoglycaemia in patients with major depression. Br J Psychiatry 1989; 155: 468-78.
37. Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996; 153: 1313-7.
38. Appels A, Bar FW, Bar J, Bruggeman C, de Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med 2000; 62: 601-5.
39. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 11-38.
40. McCaffery JM, Frasure-Smith N, Dubé M-P, Théroux P, Rouleau GA, Duan QL, et al. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med 2006; 68: 187-200.